Opinions were suggested that in order to further promote domestically developed new drugs and domestically produced raw materials, preferential drug prices are necessary. For new drugs developed domestically, the additional system should be used more actively and reference prices should be given to support exports. In order to increase the 20% level of self-sufficiency in raw material drugs, it is an opinion that the system of preferential drug prices for finished drugs using domestic raw materials should be revived.

On the afternoon of the 9th, at the 'Policy Debate for the Advancement of the Global Center for Pharmaceutical Bio' (subtitle: Appropriate value of new drugs and measures to vitalize the r